Table 1.

NMR data of sanguinamide A, 7 (600 MHz, CDCl₃)

	#	δCa, mult.	δH, mult. (J in Hz)	HMBC b
L-Pro-1
	1	170.6, qC
	2	60.8, CH	4.67, d (7.9)	1, 6
	3	30.5, CH2	1.81, m	1, 4, 5
			2.68, dd (12.0, 5.2)
	4	25.0, CH2	1.90, 2.02, m	2
	5	48.1, CH2	3.67, 4.00, m	4
L-Ile-1
	6	174.5, qC
	7	56.3, CH	4.26, dd (10.0, 7.2)	6, 8, 9, 12
	8	35.5, CH	2.30, m
	9	25.3, CH2	1.24, 1.70, m	8, 10
	10	15.1, CH3	1.02, d (6.8)	7, 8, 9
	11	10.3, CH3	0.91, t (7.6)	8, 9
	NH		9.19, d (7.2)	12
L-Pro-2
	12	171.50, qC
	13	60.9, CH	3.38, d (7.6)	12, 17
	14	30.4, CH2	0.93,	12, 16
			m 2.10, dd (12.2, 6.1)
	15	22.0, CH2	1.70, 1.50, m	13
	16	46.3, CH2	3.50, 3.53, m	15
L-Phe
	17	169.2, qC
	18	54.5, CH	4.22, ddd (10.1, 5.8, 1.7)	19, 26
	19	37.9, CH2	2.98, dd (11.9, 5.8)	17
			3.08, (11.9, 11.9)
	20	134.3, qC
	21	129.3, CH	7.16, d (7.10)	20, 22, 23
	22	127.8, CH	7.24, m
	23	129.1, CH	7.28, m
	NH		6.11, br s
L-Ala
	26	171.0, qC
	27	49.1, CH	4.69, qd (7.8, 6.4)	26, 28, 29
	28	17.9, CH3	1.48, d (6.4)	26, 27
	NH		8.11, d (7.8)	26, 29
Thz
	29	160.3, qC
	30	148.5, qC	-
	31	123.1, CH	8.01, s	29, 30, 32
	32	168.1, qC
L-Ile-2
	33	56.3, CH	5.09, dd (7.2, 7.2)	1, 32, 34, 35
	34	40.9, CH	1.80, m	35
	35	25.9, CH2	1.17, 1.50, m	34, 36
	36	15.0, CH3	0.77, d (6.7)	33, 34, 35
	37	10.3, CH3	0.91, t (7.6)	34, 35
	NH		8.78, d (7.2)	1, 32

^aδ’s measured by indirect detection, HSQC and HMBC (¹J_CH= 6 Hz)

^b1H->¹³C.